Effect of prophylactic anticoagulation on the incidence of venous thromboembolism in patients with testicular germ cell tumor. Article Swipe
Nikola Hapakova
,
Michal Chovanec
,
Katarína Rejleková
,
Katarína Kaľavská
,
Jana Obertová
,
Patrik Palacka
,
Valentina De Angelis
,
Zuzana Syčová-Milá
,
Jozef Mardiak
,
Michal Mego
·
YOU?
·
· 2020
· Open Access
·
· DOI: https://doi.org/10.21203/rs.3.rs-20044/v2
YOU?
·
· 2020
· Open Access
·
· DOI: https://doi.org/10.21203/rs.3.rs-20044/v2
Background Testicular germ cell tumors (GCTs) are among the most common solid tumors in young males. With the availability of highly effective treatment, improving patients’ quality of life has gained more focus in recent years. Venous thromboembolism (VTE), commonly occurring in patients with GCT, is associated with increased morbidity and mortality. Prophylactic anticoagulation has been shown to decrease the risk of VTE in patients with malignancy. The aim of this retrospective study was to evaluate the effect of low-molecular-weight heparin (LMWH) prophylaxis on the incidence of VTE and outcome in patients with GCT treated with first-line chemotherapy. Methods Our study population included chemotherapy-naive patients with GCT treated with first-line chemotherapy at the National Cancer Institute, Bratislava, Slovakia, from January 2000 to December 2017. VTE was defined as any venous thrombosis or pulmonary embolism, confirmed by imaging, occurring during first-line chemotherapy. Patients diagnosed with VTE on initial staging exam were excluded from the study. No visceral thromboses were observed. Results Our cohort included 353 patients with GCT. LMWH prophylaxis was administered to 104 patients (29.5%), and 249 patients (70.5%) did not receive prophylaxis. We observed 14 (4.0%) VTE events. The difference in VTE incidence between patients with and without prophylaxis was not statistically significant (5.8% vs. 3.2% P = 0.37). We observed a trend toward longer overall survival in patients without prophylaxis (hazard ratio = 0.61, 95% confidence interval = 0.32-1.13, p = 0.08). Patients with extragonadal GCT receiving VTE prophylaxis had significantly shorter survival (hazard ratio = 0.29, 95% confidence interval = 0.08-1.12, P = 0.04). This effect was most likely driven by a higher incidence of treatment-related deaths in patients with extragonadal GCT receiving LMWH ( P = 0.06). Conclusions LMWH prophylaxis was not associated with decreased VTE incidence.Moreover, there was a higher incidence of treatment-related deaths in patients with extragonadal tumor location. LMWH prophylaxis during hospitalization should not be used routinely in patients with GCT receiving chemotherapy.
Related Topics
Concepts
Metadata
- Type
- preprint
- Language
- en
- Landing Page
- https://doi.org/10.21203/rs.3.rs-20044/v2
- https://www.researchsquare.com/article/rs-20044/latest.pdf
- OA Status
- green
- References
- 17
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4255902610
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4255902610Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.21203/rs.3.rs-20044/v2Digital Object Identifier
- Title
-
Effect of prophylactic anticoagulation on the incidence of venous thromboembolism in patients with testicular germ cell tumor.Work title
- Type
-
preprintOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2020Year of publication
- Publication date
-
2020-08-11Full publication date if available
- Authors
-
Nikola Hapakova, Michal Chovanec, Katarína Rejleková, Katarína Kaľavská, Jana Obertová, Patrik Palacka, Valentina De Angelis, Zuzana Syčová-Milá, Jozef Mardiak, Michal MegoList of authors in order
- Landing page
-
https://doi.org/10.21203/rs.3.rs-20044/v2Publisher landing page
- PDF URL
-
https://www.researchsquare.com/article/rs-20044/latest.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
greenOpen access status per OpenAlex
- OA URL
-
https://www.researchsquare.com/article/rs-20044/latest.pdfDirect OA link when available
- Concepts
-
Medicine, Incidence (geometry), Pulmonary embolism, Chemotherapy, Malignancy, Hazard ratio, Testicular cancer, Testicular Germ Cell Tumor, Internal medicine, Population, Cancer, Retrospective cohort study, Low molecular weight heparin, Thrombosis, Confidence interval, Surgery, Physics, Optics, Environmental healthTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- References (count)
-
17Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4255902610 |
|---|---|
| doi | https://doi.org/10.21203/rs.3.rs-20044/v2 |
| ids.doi | https://doi.org/10.21203/rs.3.rs-20044/v2 |
| ids.openalex | https://openalex.org/W4255902610 |
| fwci | |
| type | preprint |
| title | Effect of prophylactic anticoagulation on the incidence of venous thromboembolism in patients with testicular germ cell tumor. |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T10285 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9984999895095825 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2724 |
| topics[0].subfield.display_name | Internal Medicine |
| topics[0].display_name | Venous Thromboembolism Diagnosis and Management |
| topics[1].id | https://openalex.org/T11054 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9979000091552734 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2746 |
| topics[1].subfield.display_name | Surgery |
| topics[1].display_name | Adrenal and Paraganglionic Tumors |
| topics[2].id | https://openalex.org/T11638 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9947999715805054 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2705 |
| topics[2].subfield.display_name | Cardiology and Cardiovascular Medicine |
| topics[2].display_name | Cardiac tumors and thrombi |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.9281256794929504 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C61511704 |
| concepts[1].level | 2 |
| concepts[1].score | 0.6003771424293518 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q1671857 |
| concepts[1].display_name | Incidence (geometry) |
| concepts[2].id | https://openalex.org/C2776265017 |
| concepts[2].level | 2 |
| concepts[2].score | 0.5916619300842285 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q220570 |
| concepts[2].display_name | Pulmonary embolism |
| concepts[3].id | https://openalex.org/C2776694085 |
| concepts[3].level | 2 |
| concepts[3].score | 0.5697156190872192 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q974135 |
| concepts[3].display_name | Chemotherapy |
| concepts[4].id | https://openalex.org/C2779399171 |
| concepts[4].level | 2 |
| concepts[4].score | 0.5696625709533691 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q1483951 |
| concepts[4].display_name | Malignancy |
| concepts[5].id | https://openalex.org/C207103383 |
| concepts[5].level | 3 |
| concepts[5].score | 0.5694339275360107 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q3930246 |
| concepts[5].display_name | Hazard ratio |
| concepts[6].id | https://openalex.org/C2776212926 |
| concepts[6].level | 3 |
| concepts[6].score | 0.5286990404129028 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q324464 |
| concepts[6].display_name | Testicular cancer |
| concepts[7].id | https://openalex.org/C2911180711 |
| concepts[7].level | 4 |
| concepts[7].score | 0.5169950723648071 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q1737977 |
| concepts[7].display_name | Testicular Germ Cell Tumor |
| concepts[8].id | https://openalex.org/C126322002 |
| concepts[8].level | 1 |
| concepts[8].score | 0.49539053440093994 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[8].display_name | Internal medicine |
| concepts[9].id | https://openalex.org/C2908647359 |
| concepts[9].level | 2 |
| concepts[9].score | 0.46391716599464417 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q2625603 |
| concepts[9].display_name | Population |
| concepts[10].id | https://openalex.org/C121608353 |
| concepts[10].level | 2 |
| concepts[10].score | 0.4612051844596863 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[10].display_name | Cancer |
| concepts[11].id | https://openalex.org/C167135981 |
| concepts[11].level | 2 |
| concepts[11].score | 0.4601574242115021 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q2146302 |
| concepts[11].display_name | Retrospective cohort study |
| concepts[12].id | https://openalex.org/C2776884760 |
| concepts[12].level | 3 |
| concepts[12].score | 0.4482366442680359 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q2750727 |
| concepts[12].display_name | Low molecular weight heparin |
| concepts[13].id | https://openalex.org/C2780868729 |
| concepts[13].level | 2 |
| concepts[13].score | 0.41600289940834045 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q261327 |
| concepts[13].display_name | Thrombosis |
| concepts[14].id | https://openalex.org/C44249647 |
| concepts[14].level | 2 |
| concepts[14].score | 0.40732628107070923 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q208498 |
| concepts[14].display_name | Confidence interval |
| concepts[15].id | https://openalex.org/C141071460 |
| concepts[15].level | 1 |
| concepts[15].score | 0.37617945671081543 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q40821 |
| concepts[15].display_name | Surgery |
| concepts[16].id | https://openalex.org/C121332964 |
| concepts[16].level | 0 |
| concepts[16].score | 0.0 |
| concepts[16].wikidata | https://www.wikidata.org/wiki/Q413 |
| concepts[16].display_name | Physics |
| concepts[17].id | https://openalex.org/C120665830 |
| concepts[17].level | 1 |
| concepts[17].score | 0.0 |
| concepts[17].wikidata | https://www.wikidata.org/wiki/Q14620 |
| concepts[17].display_name | Optics |
| concepts[18].id | https://openalex.org/C99454951 |
| concepts[18].level | 1 |
| concepts[18].score | 0.0 |
| concepts[18].wikidata | https://www.wikidata.org/wiki/Q932068 |
| concepts[18].display_name | Environmental health |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.9281256794929504 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/incidence |
| keywords[1].score | 0.6003771424293518 |
| keywords[1].display_name | Incidence (geometry) |
| keywords[2].id | https://openalex.org/keywords/pulmonary-embolism |
| keywords[2].score | 0.5916619300842285 |
| keywords[2].display_name | Pulmonary embolism |
| keywords[3].id | https://openalex.org/keywords/chemotherapy |
| keywords[3].score | 0.5697156190872192 |
| keywords[3].display_name | Chemotherapy |
| keywords[4].id | https://openalex.org/keywords/malignancy |
| keywords[4].score | 0.5696625709533691 |
| keywords[4].display_name | Malignancy |
| keywords[5].id | https://openalex.org/keywords/hazard-ratio |
| keywords[5].score | 0.5694339275360107 |
| keywords[5].display_name | Hazard ratio |
| keywords[6].id | https://openalex.org/keywords/testicular-cancer |
| keywords[6].score | 0.5286990404129028 |
| keywords[6].display_name | Testicular cancer |
| keywords[7].id | https://openalex.org/keywords/testicular-germ-cell-tumor |
| keywords[7].score | 0.5169950723648071 |
| keywords[7].display_name | Testicular Germ Cell Tumor |
| keywords[8].id | https://openalex.org/keywords/internal-medicine |
| keywords[8].score | 0.49539053440093994 |
| keywords[8].display_name | Internal medicine |
| keywords[9].id | https://openalex.org/keywords/population |
| keywords[9].score | 0.46391716599464417 |
| keywords[9].display_name | Population |
| keywords[10].id | https://openalex.org/keywords/cancer |
| keywords[10].score | 0.4612051844596863 |
| keywords[10].display_name | Cancer |
| keywords[11].id | https://openalex.org/keywords/retrospective-cohort-study |
| keywords[11].score | 0.4601574242115021 |
| keywords[11].display_name | Retrospective cohort study |
| keywords[12].id | https://openalex.org/keywords/low-molecular-weight-heparin |
| keywords[12].score | 0.4482366442680359 |
| keywords[12].display_name | Low molecular weight heparin |
| keywords[13].id | https://openalex.org/keywords/thrombosis |
| keywords[13].score | 0.41600289940834045 |
| keywords[13].display_name | Thrombosis |
| keywords[14].id | https://openalex.org/keywords/confidence-interval |
| keywords[14].score | 0.40732628107070923 |
| keywords[14].display_name | Confidence interval |
| keywords[15].id | https://openalex.org/keywords/surgery |
| keywords[15].score | 0.37617945671081543 |
| keywords[15].display_name | Surgery |
| language | en |
| locations[0].id | doi:10.21203/rs.3.rs-20044/v2 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S4306402450 |
| locations[0].source.issn | |
| locations[0].source.type | repository |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | |
| locations[0].source.is_core | False |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Research Square (Research Square) |
| locations[0].source.host_organization | https://openalex.org/I4210096694 |
| locations[0].source.host_organization_name | Research Square (United States) |
| locations[0].source.host_organization_lineage | https://openalex.org/I4210096694 |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://www.researchsquare.com/article/rs-20044/latest.pdf |
| locations[0].version | acceptedVersion |
| locations[0].raw_type | posted-content |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | False |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | https://doi.org/10.21203/rs.3.rs-20044/v2 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5001600545 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Nikola Hapakova |
| authorships[0].countries | SK |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I74788687 |
| authorships[0].affiliations[0].raw_affiliation_string | Comenius University, Faculty of Medicine, National Cancer Institute, Bratislava, Slovakia |
| authorships[0].institutions[0].id | https://openalex.org/I74788687 |
| authorships[0].institutions[0].ror | https://ror.org/0587ef340 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I74788687 |
| authorships[0].institutions[0].country_code | SK |
| authorships[0].institutions[0].display_name | Comenius University Bratislava |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Nikola Hapakova |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Comenius University, Faculty of Medicine, National Cancer Institute, Bratislava, Slovakia |
| authorships[1].author.id | https://openalex.org/A5009013764 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-5653-2909 |
| authorships[1].author.display_name | Michal Chovanec |
| authorships[1].countries | SK |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I74788687 |
| authorships[1].affiliations[0].raw_affiliation_string | Comenius University, Faculty of Medicine; National Cancer Institute, Bratislava, Slovakia |
| authorships[1].institutions[0].id | https://openalex.org/I74788687 |
| authorships[1].institutions[0].ror | https://ror.org/0587ef340 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I74788687 |
| authorships[1].institutions[0].country_code | SK |
| authorships[1].institutions[0].display_name | Comenius University Bratislava |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Michal Chovanec |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Comenius University, Faculty of Medicine; National Cancer Institute, Bratislava, Slovakia |
| authorships[2].author.id | https://openalex.org/A5014768689 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-2142-3411 |
| authorships[2].author.display_name | Katarína Rejleková |
| authorships[2].countries | SK |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I74788687 |
| authorships[2].affiliations[0].raw_affiliation_string | Comenius University, Faculty of Medicine, National Cancer Institute, Bratislava, Slovakia |
| authorships[2].institutions[0].id | https://openalex.org/I74788687 |
| authorships[2].institutions[0].ror | https://ror.org/0587ef340 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I74788687 |
| authorships[2].institutions[0].country_code | SK |
| authorships[2].institutions[0].display_name | Comenius University Bratislava |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Katarina Rejlekova |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Comenius University, Faculty of Medicine, National Cancer Institute, Bratislava, Slovakia |
| authorships[3].author.id | https://openalex.org/A5033568419 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Katarína Kaľavská |
| authorships[3].countries | SK |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I74788687 |
| authorships[3].affiliations[0].raw_affiliation_string | Comenius University, Faculty of Medicine, National Cancer Institute, Bratislava, Slovakia |
| authorships[3].institutions[0].id | https://openalex.org/I74788687 |
| authorships[3].institutions[0].ror | https://ror.org/0587ef340 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I74788687 |
| authorships[3].institutions[0].country_code | SK |
| authorships[3].institutions[0].display_name | Comenius University Bratislava |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Katarina Kalavska |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Comenius University, Faculty of Medicine, National Cancer Institute, Bratislava, Slovakia |
| authorships[4].author.id | https://openalex.org/A5077961505 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Jana Obertová |
| authorships[4].countries | SK |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I74788687 |
| authorships[4].affiliations[0].raw_affiliation_string | Comenius University, Faculty of Medicine, National Cancer Institute, Bratislava, Slovakia |
| authorships[4].institutions[0].id | https://openalex.org/I74788687 |
| authorships[4].institutions[0].ror | https://ror.org/0587ef340 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I74788687 |
| authorships[4].institutions[0].country_code | SK |
| authorships[4].institutions[0].display_name | Comenius University Bratislava |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Jana Obertova |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Comenius University, Faculty of Medicine, National Cancer Institute, Bratislava, Slovakia |
| authorships[5].author.id | https://openalex.org/A5082455939 |
| authorships[5].author.orcid | https://orcid.org/0000-0003-4505-0952 |
| authorships[5].author.display_name | Patrik Palacka |
| authorships[5].countries | SK |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I74788687 |
| authorships[5].affiliations[0].raw_affiliation_string | Comenius University, Faculty of Medicine, National Cancer Institute, Bratislava, Slovakia |
| authorships[5].institutions[0].id | https://openalex.org/I74788687 |
| authorships[5].institutions[0].ror | https://ror.org/0587ef340 |
| authorships[5].institutions[0].type | education |
| authorships[5].institutions[0].lineage | https://openalex.org/I74788687 |
| authorships[5].institutions[0].country_code | SK |
| authorships[5].institutions[0].display_name | Comenius University Bratislava |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Patrik Palacka |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Comenius University, Faculty of Medicine, National Cancer Institute, Bratislava, Slovakia |
| authorships[6].author.id | https://openalex.org/A5074195269 |
| authorships[6].author.orcid | |
| authorships[6].author.display_name | Valentina De Angelis |
| authorships[6].countries | SK |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I74788687 |
| authorships[6].affiliations[0].raw_affiliation_string | Comenius University, Faculty of Medicine, National Cancer Institute, Bratislava, Slovakia |
| authorships[6].institutions[0].id | https://openalex.org/I74788687 |
| authorships[6].institutions[0].ror | https://ror.org/0587ef340 |
| authorships[6].institutions[0].type | education |
| authorships[6].institutions[0].lineage | https://openalex.org/I74788687 |
| authorships[6].institutions[0].country_code | SK |
| authorships[6].institutions[0].display_name | Comenius University Bratislava |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Valentina De Angelis |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Comenius University, Faculty of Medicine, National Cancer Institute, Bratislava, Slovakia |
| authorships[7].author.id | https://openalex.org/A5103715586 |
| authorships[7].author.orcid | |
| authorships[7].author.display_name | Zuzana Syčová-Milá |
| authorships[7].countries | SK |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I74788687 |
| authorships[7].affiliations[0].raw_affiliation_string | Comenius University, Faculty of Medicine, National Cancer Institute, Bratislava, Slovakia |
| authorships[7].institutions[0].id | https://openalex.org/I74788687 |
| authorships[7].institutions[0].ror | https://ror.org/0587ef340 |
| authorships[7].institutions[0].type | education |
| authorships[7].institutions[0].lineage | https://openalex.org/I74788687 |
| authorships[7].institutions[0].country_code | SK |
| authorships[7].institutions[0].display_name | Comenius University Bratislava |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Zuzana Sycova-Mila |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Comenius University, Faculty of Medicine, National Cancer Institute, Bratislava, Slovakia |
| authorships[8].author.id | https://openalex.org/A5103755974 |
| authorships[8].author.orcid | |
| authorships[8].author.display_name | Jozef Mardiak |
| authorships[8].countries | SK |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I74788687 |
| authorships[8].affiliations[0].raw_affiliation_string | Comenius University, Faculty of Medicine, National Cancer Institute, Bratislava, Slovakia |
| authorships[8].institutions[0].id | https://openalex.org/I74788687 |
| authorships[8].institutions[0].ror | https://ror.org/0587ef340 |
| authorships[8].institutions[0].type | education |
| authorships[8].institutions[0].lineage | https://openalex.org/I74788687 |
| authorships[8].institutions[0].country_code | SK |
| authorships[8].institutions[0].display_name | Comenius University Bratislava |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Jozef Mardiak |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Comenius University, Faculty of Medicine, National Cancer Institute, Bratislava, Slovakia |
| authorships[9].author.id | https://openalex.org/A5050740286 |
| authorships[9].author.orcid | https://orcid.org/0000-0002-6511-6827 |
| authorships[9].author.display_name | Michal Mego |
| authorships[9].countries | IN, SK |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I2801345345, https://openalex.org/I74788687 |
| authorships[9].affiliations[0].raw_affiliation_string | Department of Oncology, Comenius University, Faculty of Medicine, National Cancer Institute Research |
| authorships[9].institutions[0].id | https://openalex.org/I2801345345 |
| authorships[9].institutions[0].ror | https://ror.org/01tc10z29 |
| authorships[9].institutions[0].type | healthcare |
| authorships[9].institutions[0].lineage | https://openalex.org/I2801345345 |
| authorships[9].institutions[0].country_code | IN |
| authorships[9].institutions[0].display_name | Cancer Institute (WIA) |
| authorships[9].institutions[1].id | https://openalex.org/I74788687 |
| authorships[9].institutions[1].ror | https://ror.org/0587ef340 |
| authorships[9].institutions[1].type | education |
| authorships[9].institutions[1].lineage | https://openalex.org/I74788687 |
| authorships[9].institutions[1].country_code | SK |
| authorships[9].institutions[1].display_name | Comenius University Bratislava |
| authorships[9].author_position | last |
| authorships[9].raw_author_name | Michal Mego |
| authorships[9].is_corresponding | True |
| authorships[9].raw_affiliation_strings | Department of Oncology, Comenius University, Faculty of Medicine, National Cancer Institute Research |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.researchsquare.com/article/rs-20044/latest.pdf |
| open_access.oa_status | green |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Effect of prophylactic anticoagulation on the incidence of venous thromboembolism in patients with testicular germ cell tumor. |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10285 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9984999895095825 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2724 |
| primary_topic.subfield.display_name | Internal Medicine |
| primary_topic.display_name | Venous Thromboembolism Diagnosis and Management |
| related_works | https://openalex.org/W1970383787, https://openalex.org/W2981730791, https://openalex.org/W1977732319, https://openalex.org/W1988855938, https://openalex.org/W3157417749, https://openalex.org/W1603374058, https://openalex.org/W3022042949, https://openalex.org/W3032655376, https://openalex.org/W2753486433, https://openalex.org/W2410020921 |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.21203/rs.3.rs-20044/v2 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4306402450 |
| best_oa_location.source.issn | |
| best_oa_location.source.type | repository |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | |
| best_oa_location.source.is_core | False |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Research Square (Research Square) |
| best_oa_location.source.host_organization | https://openalex.org/I4210096694 |
| best_oa_location.source.host_organization_name | Research Square (United States) |
| best_oa_location.source.host_organization_lineage | https://openalex.org/I4210096694 |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://www.researchsquare.com/article/rs-20044/latest.pdf |
| best_oa_location.version | acceptedVersion |
| best_oa_location.raw_type | posted-content |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://doi.org/10.21203/rs.3.rs-20044/v2 |
| primary_location.id | doi:10.21203/rs.3.rs-20044/v2 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S4306402450 |
| primary_location.source.issn | |
| primary_location.source.type | repository |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | |
| primary_location.source.is_core | False |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Research Square (Research Square) |
| primary_location.source.host_organization | https://openalex.org/I4210096694 |
| primary_location.source.host_organization_name | Research Square (United States) |
| primary_location.source.host_organization_lineage | https://openalex.org/I4210096694 |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://www.researchsquare.com/article/rs-20044/latest.pdf |
| primary_location.version | acceptedVersion |
| primary_location.raw_type | posted-content |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | https://doi.org/10.21203/rs.3.rs-20044/v2 |
| publication_date | 2020-08-11 |
| publication_year | 2020 |
| referenced_works | https://openalex.org/W6601028537, https://openalex.org/W1978515323, https://openalex.org/W3022396650, https://openalex.org/W2146022474, https://openalex.org/W2109113725, https://openalex.org/W2749725594, https://openalex.org/W2050555037, https://openalex.org/W1985832824, https://openalex.org/W2547520096, https://openalex.org/W2050157868, https://openalex.org/W1573083214, https://openalex.org/W1969827767, https://openalex.org/W2093389482, https://openalex.org/W2027917454, https://openalex.org/W2313284959, https://openalex.org/W2122625558, https://openalex.org/W2904186438 |
| referenced_works_count | 17 |
| abstract_inverted_index.( | 277 |
| abstract_inverted_index.= | 208, 224, 229, 232, 247, 252, 255, 279 |
| abstract_inverted_index.P | 207, 254, 278 |
| abstract_inverted_index.a | 212, 264, 293 |
| abstract_inverted_index.p | 231 |
| abstract_inverted_index.14 | 185 |
| abstract_inverted_index.No | 154 |
| abstract_inverted_index.We | 183, 210 |
| abstract_inverted_index.as | 127 |
| abstract_inverted_index.at | 111 |
| abstract_inverted_index.be | 311 |
| abstract_inverted_index.by | 135, 263 |
| abstract_inverted_index.in | 14, 33, 41, 63, 90, 191, 218, 270, 299, 314 |
| abstract_inverted_index.is | 45 |
| abstract_inverted_index.of | 20, 27, 61, 69, 78, 86, 267, 296 |
| abstract_inverted_index.on | 83, 145 |
| abstract_inverted_index.or | 131 |
| abstract_inverted_index.to | 57, 74, 121, 171 |
| abstract_inverted_index.104 | 172 |
| abstract_inverted_index.249 | 176 |
| abstract_inverted_index.353 | 163 |
| abstract_inverted_index.95% | 226, 249 |
| abstract_inverted_index.GCT | 93, 106, 237, 274, 317 |
| abstract_inverted_index.Our | 99, 160 |
| abstract_inverted_index.The | 67, 189 |
| abstract_inverted_index.VTE | 62, 87, 124, 144, 187, 192, 239, 289 |
| abstract_inverted_index.aim | 68 |
| abstract_inverted_index.and | 50, 88, 175, 197 |
| abstract_inverted_index.any | 128 |
| abstract_inverted_index.are | 7 |
| abstract_inverted_index.did | 179 |
| abstract_inverted_index.had | 241 |
| abstract_inverted_index.has | 29, 54 |
| abstract_inverted_index.not | 180, 201, 285, 310 |
| abstract_inverted_index.the | 9, 18, 59, 76, 84, 112, 152 |
| abstract_inverted_index.vs. | 205 |
| abstract_inverted_index.was | 73, 125, 169, 200, 259, 284, 292 |
| abstract_inverted_index.2000 | 120 |
| abstract_inverted_index.3.2% | 206 |
| abstract_inverted_index.GCT, | 44 |
| abstract_inverted_index.GCT. | 166 |
| abstract_inverted_index.LMWH | 167, 276, 282, 305 |
| abstract_inverted_index.This | 257 |
| abstract_inverted_index.With | 17 |
| abstract_inverted_index.been | 55 |
| abstract_inverted_index.cell | 4 |
| abstract_inverted_index.exam | 148 |
| abstract_inverted_index.from | 118, 151 |
| abstract_inverted_index.germ | 3 |
| abstract_inverted_index.life | 28 |
| abstract_inverted_index.more | 31 |
| abstract_inverted_index.most | 10, 260 |
| abstract_inverted_index.risk | 60 |
| abstract_inverted_index.this | 70 |
| abstract_inverted_index.used | 312 |
| abstract_inverted_index.were | 149, 157 |
| abstract_inverted_index.with | 43, 47, 65, 92, 95, 105, 108, 143, 165, 196, 235, 272, 287, 301, 316 |
| abstract_inverted_index.(5.8% | 204 |
| abstract_inverted_index.0.29, | 248 |
| abstract_inverted_index.0.61, | 225 |
| abstract_inverted_index.2017. | 123 |
| abstract_inverted_index.among | 8 |
| abstract_inverted_index.focus | 32 |
| abstract_inverted_index.ratio | 223, 246 |
| abstract_inverted_index.shown | 56 |
| abstract_inverted_index.solid | 12 |
| abstract_inverted_index.study | 72, 100 |
| abstract_inverted_index.there | 291 |
| abstract_inverted_index.trend | 213 |
| abstract_inverted_index.tumor | 303 |
| abstract_inverted_index.young | 15 |
| abstract_inverted_index.(4.0%) | 186 |
| abstract_inverted_index.(GCTs) | 6 |
| abstract_inverted_index.(LMWH) | 81 |
| abstract_inverted_index.(VTE), | 38 |
| abstract_inverted_index.0.04). | 256 |
| abstract_inverted_index.0.06). | 280 |
| abstract_inverted_index.0.08). | 233 |
| abstract_inverted_index.0.37). | 209 |
| abstract_inverted_index.Cancer | 114 |
| abstract_inverted_index.Venous | 36 |
| abstract_inverted_index.cohort | 161 |
| abstract_inverted_index.common | 11 |
| abstract_inverted_index.deaths | 269, 298 |
| abstract_inverted_index.driven | 262 |
| abstract_inverted_index.during | 138, 307 |
| abstract_inverted_index.effect | 77, 258 |
| abstract_inverted_index.gained | 30 |
| abstract_inverted_index.higher | 265, 294 |
| abstract_inverted_index.highly | 21 |
| abstract_inverted_index.likely | 261 |
| abstract_inverted_index.longer | 215 |
| abstract_inverted_index.males. | 16 |
| abstract_inverted_index.recent | 34 |
| abstract_inverted_index.should | 309 |
| abstract_inverted_index.study. | 153 |
| abstract_inverted_index.toward | 214 |
| abstract_inverted_index.tumors | 5, 13 |
| abstract_inverted_index.venous | 129 |
| abstract_inverted_index.years. | 35 |
| abstract_inverted_index.(70.5%) | 178 |
| abstract_inverted_index.(hazard | 222, 245 |
| abstract_inverted_index.January | 119 |
| abstract_inverted_index.Methods | 98 |
| abstract_inverted_index.Results | 159 |
| abstract_inverted_index.between | 194 |
| abstract_inverted_index.defined | 126 |
| abstract_inverted_index.events. | 188 |
| abstract_inverted_index.heparin | 80 |
| abstract_inverted_index.initial | 146 |
| abstract_inverted_index.outcome | 89 |
| abstract_inverted_index.overall | 216 |
| abstract_inverted_index.quality | 26 |
| abstract_inverted_index.receive | 181 |
| abstract_inverted_index.shorter | 243 |
| abstract_inverted_index.staging | 147 |
| abstract_inverted_index.treated | 94, 107 |
| abstract_inverted_index.without | 198, 220 |
| abstract_inverted_index.(29.5%), | 174 |
| abstract_inverted_index.Abstract | 0 |
| abstract_inverted_index.December | 122 |
| abstract_inverted_index.National | 113 |
| abstract_inverted_index.Patients | 141, 234 |
| abstract_inverted_index.commonly | 39 |
| abstract_inverted_index.decrease | 58 |
| abstract_inverted_index.evaluate | 75 |
| abstract_inverted_index.excluded | 150 |
| abstract_inverted_index.imaging, | 136 |
| abstract_inverted_index.included | 102, 162 |
| abstract_inverted_index.interval | 228, 251 |
| abstract_inverted_index.observed | 184, 211 |
| abstract_inverted_index.patients | 42, 64, 91, 104, 164, 173, 177, 195, 219, 271, 300, 315 |
| abstract_inverted_index.survival | 217, 244 |
| abstract_inverted_index.visceral | 155 |
| abstract_inverted_index.Slovakia, | 117 |
| abstract_inverted_index.confirmed | 134 |
| abstract_inverted_index.decreased | 288 |
| abstract_inverted_index.diagnosed | 142 |
| abstract_inverted_index.effective | 22 |
| abstract_inverted_index.embolism, | 133 |
| abstract_inverted_index.improving | 24 |
| abstract_inverted_index.incidence | 85, 193, 266, 295 |
| abstract_inverted_index.increased | 48 |
| abstract_inverted_index.location. | 304 |
| abstract_inverted_index.morbidity | 49 |
| abstract_inverted_index.observed. | 158 |
| abstract_inverted_index.occurring | 40, 137 |
| abstract_inverted_index.pulmonary | 132 |
| abstract_inverted_index.receiving | 238, 275, 318 |
| abstract_inverted_index.routinely | 313 |
| abstract_inverted_index.0.08-1.12, | 253 |
| abstract_inverted_index.0.32-1.13, | 230 |
| abstract_inverted_index.Background | 1 |
| abstract_inverted_index.Institute, | 115 |
| abstract_inverted_index.Testicular | 2 |
| abstract_inverted_index.associated | 46, 286 |
| abstract_inverted_index.confidence | 227, 250 |
| abstract_inverted_index.difference | 190 |
| abstract_inverted_index.first-line | 96, 109, 139 |
| abstract_inverted_index.mortality. | 51 |
| abstract_inverted_index.population | 101 |
| abstract_inverted_index.thromboses | 156 |
| abstract_inverted_index.thrombosis | 130 |
| abstract_inverted_index.treatment, | 23 |
| abstract_inverted_index.Bratislava, | 116 |
| abstract_inverted_index.Conclusions | 281 |
| abstract_inverted_index.malignancy. | 66 |
| abstract_inverted_index.patients’ | 25 |
| abstract_inverted_index.prophylaxis | 82, 168, 199, 221, 240, 283, 306 |
| abstract_inverted_index.significant | 203 |
| abstract_inverted_index.Prophylactic | 52 |
| abstract_inverted_index.administered | 170 |
| abstract_inverted_index.availability | 19 |
| abstract_inverted_index.chemotherapy | 110 |
| abstract_inverted_index.extragonadal | 236, 273, 302 |
| abstract_inverted_index.prophylaxis. | 182 |
| abstract_inverted_index.chemotherapy. | 97, 140, 319 |
| abstract_inverted_index.retrospective | 71 |
| abstract_inverted_index.significantly | 242 |
| abstract_inverted_index.statistically | 202 |
| abstract_inverted_index.anticoagulation | 53 |
| abstract_inverted_index.hospitalization | 308 |
| abstract_inverted_index.thromboembolism | 37 |
| abstract_inverted_index.treatment-related | 268, 297 |
| abstract_inverted_index.chemotherapy-naive | 103 |
| abstract_inverted_index.incidence.Moreover, | 290 |
| abstract_inverted_index.low-molecular-weight | 79 |
| cited_by_percentile_year | |
| corresponding_author_ids | https://openalex.org/A5050740286 |
| countries_distinct_count | 2 |
| institutions_distinct_count | 10 |
| corresponding_institution_ids | https://openalex.org/I2801345345, https://openalex.org/I74788687 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8600000143051147 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.40821781 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |